Travel and migration associated infectious diseases morbidity in Europe, 2008
<p>Abstract</p> <p>Background</p> <p>Europeans represent the majority of international travellers and clinicians encountering returned patients have an essential role in recognizing, and communicating travel-associated public health risks.</p> <p>Methods<...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-11-01
|
Series: | BMC Infectious Diseases |
Online Access: | http://www.biomedcentral.com/1471-2334/10/330 |
id |
doaj-fd1bcdc7dd894a769007b397b04db8bb |
---|---|
record_format |
Article |
spelling |
doaj-fd1bcdc7dd894a769007b397b04db8bb2020-11-25T03:49:34ZengBMCBMC Infectious Diseases1471-23342010-11-0110133010.1186/1471-2334-10-330Travel and migration associated infectious diseases morbidity in Europe, 2008Lopez-Velez RogelioWeld LeisaGkrania-Klotsas EffrossyniCastelli FrancescoJensenius MogensCaumes EricBurchard Gerd-DieterSchlagenhauf PatriciaGautret PhilippeField Vanessade Vries Petervon Sonnenburg FrankLoutan LouisParola Philippe<p>Abstract</p> <p>Background</p> <p>Europeans represent the majority of international travellers and clinicians encountering returned patients have an essential role in recognizing, and communicating travel-associated public health risks.</p> <p>Methods</p> <p>To investigate the morbidity of travel associated infectious diseases in European travellers, we analysed diagnoses with demographic, clinical and travel-related predictors of disease, in 6957 ill returned travellers who presented in 2008 to EuroTravNet centres with a presumed travel associated condition.</p> <p>Results</p> <p>Gastro-intestinal (GI) diseases accounted for 33% of illnesses, followed by febrile systemic illnesses (20%), dermatological conditions (12%) and respiratory illnesses (8%). There were 3 deaths recorded; a sepsis caused by <it>Escherichia coli </it>pyelonephritis, a dengue shock syndrome and a <it>Plasmodium falciparum </it>malaria.</p> <p>GI conditions included bacterial acute diarrhea (6.9%), as well as giardiasis and amebasis (2.3%). Among febrile systemic illnesses with identified pathogens, malaria (5.4%) accounted for most cases followed by dengue (1.9%) and others including chikungunya, rickettsial diseases, leptospirosis, brucellosis, Epstein Barr virus infections, tick-borne encephalitis (TBE) and viral hepatitis. Dermatological conditions were dominated by bacterial infections, arthropod bites, cutaneous larva migrans and animal bites requiring rabies post-exposure prophylaxis and also leishmaniasis, myasis, tungiasis and one case of leprosy. Respiratory illness included 112 cases of tuberculosis including cases of multi-drug resistant or extensively drug resistant tuberculosis, 104 cases of influenza like illness, and 5 cases of Legionnaires disease. Sexually transmitted infections (STI) accounted for 0.6% of total diagnoses and included HIV infection and syphilis. A total of 165 cases of potentially vaccine preventable diseases were reported. Purpose of travel and destination specific risk factors was identified for several diagnoses such as Chagas disease in immigrant travellers from South America and <it>P. falciparum </it>malaria in immigrants from sub-Saharan Africa. Travel within Europe was also associated with health risks with distinctive profiles for Eastern and Western Europe.</p> <p>Conclusions</p> <p>In 2008, a broad spectrum of travel associated diseases were diagnosed at EuroTravNet core sites. Diagnoses varied according to regions visited by ill travellers. The spectrum of travel associated morbidity also shows that there is a need to dispel the misconception that travel, close to home, in Europe, is without significant health risk.</p> http://www.biomedcentral.com/1471-2334/10/330 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Lopez-Velez Rogelio Weld Leisa Gkrania-Klotsas Effrossyni Castelli Francesco Jensenius Mogens Caumes Eric Burchard Gerd-Dieter Schlagenhauf Patricia Gautret Philippe Field Vanessa de Vries Peter von Sonnenburg Frank Loutan Louis Parola Philippe |
spellingShingle |
Lopez-Velez Rogelio Weld Leisa Gkrania-Klotsas Effrossyni Castelli Francesco Jensenius Mogens Caumes Eric Burchard Gerd-Dieter Schlagenhauf Patricia Gautret Philippe Field Vanessa de Vries Peter von Sonnenburg Frank Loutan Louis Parola Philippe Travel and migration associated infectious diseases morbidity in Europe, 2008 BMC Infectious Diseases |
author_facet |
Lopez-Velez Rogelio Weld Leisa Gkrania-Klotsas Effrossyni Castelli Francesco Jensenius Mogens Caumes Eric Burchard Gerd-Dieter Schlagenhauf Patricia Gautret Philippe Field Vanessa de Vries Peter von Sonnenburg Frank Loutan Louis Parola Philippe |
author_sort |
Lopez-Velez Rogelio |
title |
Travel and migration associated infectious diseases morbidity in Europe, 2008 |
title_short |
Travel and migration associated infectious diseases morbidity in Europe, 2008 |
title_full |
Travel and migration associated infectious diseases morbidity in Europe, 2008 |
title_fullStr |
Travel and migration associated infectious diseases morbidity in Europe, 2008 |
title_full_unstemmed |
Travel and migration associated infectious diseases morbidity in Europe, 2008 |
title_sort |
travel and migration associated infectious diseases morbidity in europe, 2008 |
publisher |
BMC |
series |
BMC Infectious Diseases |
issn |
1471-2334 |
publishDate |
2010-11-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Europeans represent the majority of international travellers and clinicians encountering returned patients have an essential role in recognizing, and communicating travel-associated public health risks.</p> <p>Methods</p> <p>To investigate the morbidity of travel associated infectious diseases in European travellers, we analysed diagnoses with demographic, clinical and travel-related predictors of disease, in 6957 ill returned travellers who presented in 2008 to EuroTravNet centres with a presumed travel associated condition.</p> <p>Results</p> <p>Gastro-intestinal (GI) diseases accounted for 33% of illnesses, followed by febrile systemic illnesses (20%), dermatological conditions (12%) and respiratory illnesses (8%). There were 3 deaths recorded; a sepsis caused by <it>Escherichia coli </it>pyelonephritis, a dengue shock syndrome and a <it>Plasmodium falciparum </it>malaria.</p> <p>GI conditions included bacterial acute diarrhea (6.9%), as well as giardiasis and amebasis (2.3%). Among febrile systemic illnesses with identified pathogens, malaria (5.4%) accounted for most cases followed by dengue (1.9%) and others including chikungunya, rickettsial diseases, leptospirosis, brucellosis, Epstein Barr virus infections, tick-borne encephalitis (TBE) and viral hepatitis. Dermatological conditions were dominated by bacterial infections, arthropod bites, cutaneous larva migrans and animal bites requiring rabies post-exposure prophylaxis and also leishmaniasis, myasis, tungiasis and one case of leprosy. Respiratory illness included 112 cases of tuberculosis including cases of multi-drug resistant or extensively drug resistant tuberculosis, 104 cases of influenza like illness, and 5 cases of Legionnaires disease. Sexually transmitted infections (STI) accounted for 0.6% of total diagnoses and included HIV infection and syphilis. A total of 165 cases of potentially vaccine preventable diseases were reported. Purpose of travel and destination specific risk factors was identified for several diagnoses such as Chagas disease in immigrant travellers from South America and <it>P. falciparum </it>malaria in immigrants from sub-Saharan Africa. Travel within Europe was also associated with health risks with distinctive profiles for Eastern and Western Europe.</p> <p>Conclusions</p> <p>In 2008, a broad spectrum of travel associated diseases were diagnosed at EuroTravNet core sites. Diagnoses varied according to regions visited by ill travellers. The spectrum of travel associated morbidity also shows that there is a need to dispel the misconception that travel, close to home, in Europe, is without significant health risk.</p> |
url |
http://www.biomedcentral.com/1471-2334/10/330 |
work_keys_str_mv |
AT lopezvelezrogelio travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008 AT weldleisa travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008 AT gkraniaklotsaseffrossyni travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008 AT castellifrancesco travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008 AT jenseniusmogens travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008 AT caumeseric travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008 AT burchardgerddieter travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008 AT schlagenhaufpatricia travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008 AT gautretphilippe travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008 AT fieldvanessa travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008 AT devriespeter travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008 AT vonsonnenburgfrank travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008 AT loutanlouis travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008 AT parolaphilippe travelandmigrationassociatedinfectiousdiseasesmorbidityineurope2008 |
_version_ |
1724494779985690624 |